Walleye Trading LLC

Position in PTGX — Protagonist Therapeutics, Inc

CIK 1388391 NEW YORK, NY

Back to PTGX Full portfolio

Position in PTGX

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

+$0 QoQ

Shares Held

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

5 quarters on record

Common Shares in PTGX Over Time

Shares Held

Position Value (USD)

Derivatives in PTGX

reported options exposure · as of Mar 31, 2026

CallValue

$1,549,380

CallShares

14,700

PutValue

$453,220

PutShares

4,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Walleye Trading LLC holds $28,211,005 across 28 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	11,407	$7,112,720
2	MRNA	Moderna, Inc.	101,066	$7,077,651
3	BNTX	BioNTech SE	25,690	$2,390,454
4	ALNY	Alnylam Pharmaceuticals, Inc.	6,037	$1,817,318
5	VKTX	Viking Therapeutics, Inc.	33,938	$1,323,921
6	TGTX	Tg Therapeutics, Inc.	19,679	$1,081,164
7	CRSP	CRISPR Therapeutics AG	18,595	$1,014,171
8	ABVX	Abivax S.A.	6,790	$904,835

All Filings in PTGX

Export CSV

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$453,220	4,300	-10.4%	Put	Sole	2026-05-11
2026-03-31	$1,549,380	14,700	-24.2%	Call	Sole	2026-05-11
2025-12-31	$419,232	4,800	-46.1%	Put	Sole	2026-02-13
2025-12-31	$1,694,396	19,400	+506.2%	Call	Sole	2026-02-13
2023-06-30	$88,384	3,200	+146.2%	Call	Sole	2023-08-14
2023-06-30	$245,818	8,900	-9.2%	Put	Sole	2023-08-14
2023-03-31	$29,900	1,300	—	Call	Sole	2023-05-15
2023-03-31	$2,423,280	105,360	+112.8%	Shares	Sole	2023-05-15
2023-03-31	$225,400	9,800	—	Put	Sole	2023-05-15
2022-12-31	$540,143	49,509	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.